COPN: World COPD Day in Czech Republic
EFA’s member the Czech Civic Association Against Lung Diseases (COPN), in cooperation with Czech Pneumological and Phthisiological Society, created online...
EFA President Mikaela Odemyr elected as chair of the ELF Patient Advisory Committee (PAC)
EFA President Mikaela Odemyr was elected as Chair of the European Lung Foundation (ELF)’s Patient Advisory Committee (PAC) in August 2020.
In an interview...
EP Interest Group on Allergy and Asthma: Launch of the Youth Parliament's recommendations
On Thursday 10 December, the European Parliament Interest Group on Allergy & Asthma hosted a digital launch for guidelines created by the the Allergy...
How do you care for atopic eczema? EFA at the EADV Virtual Congress
Representing European atopic eczema patients, EFA took part in the annual Congress of the European Academy of Dermatology and Venerology (EADV) that...
Europe’s Zero Pollution Action Plan: the chance for an air quality framework for better health
Clean air is central to human health and essential to the wellbeing and quality of life for people with allergies and airways diseases.
In 2021, the European...
The EU’s Renovation Wave champions green homes to reduce pollution but lacks health as a priority
This month the European Commission published its Renovation Wave Strategy. This strategy outlines detailed plans to increase the energy efficiency of building...
Highlights from the Annual Stakeholder meeting of the EU Human Biomonitoring project – HBM4EU
EFA participated and gave a short presentation to the Annual Stakeholder Forum of the EU Human Biomonitoring project on 30 September. The project, called...
European Parliament pushes for a 60% emissions reduction target in the new Climate Law
At the start of October, the European Parliament voted to adopt an EU Climate Law with increased ambitions. The biggest news was MEPs calling for a 60%...
EFA participates in the 43rd Session of the Codex Alimentarius Commission
The 43rd annual session of the Codex Alimentarius Commission (CAC) was held from 24-26th September, and 12th and 19th October. It will also take place...
EFA allergy and respiratory patients conference
Digitalisation brings an enormous potential to improve health and care and the lives of patients. With new and emerging technologies, healthcare systems...
EFA response to the new EU Pharmaceutical Strategy: towards safe and more accessible medicines
Launched in the midst of the COVID-19 crisis, the EU Pharmaceutical Strategy draft is an initiative that, along with the Beating Cancer Plan, tops the...
AEPNAA releases guide on food allergies for educational centres in Spain
EFA Member the Spanish Association of People with Food and Latex Allergy (AEPNAA) have created a guide for educational centres in Spain to understand food...
New Danish study on peanut allergies
EFA Member Asthma-Allergy Denmark has contributed to a study which reveals how peanut allergy affects the psyche. The study explored how limitations in...
Longfonds supports study of COVID-19 effect on lung tissue
Longfonds have supported a study by LUMC where scientists are investigating how lung tissue reacts to the coronavirus. This research uses a so-called Long...
Smoking ban extended to e-cigarettes in the Netherlands
Vaping and vaporising is no longer allowed in public from 1 July in the Netherlands, as part of an extension of the smoking ban to include e-cigarettes. This...
We joined World Patient Safety Day on September 17th!
17th September is celebrated around the world as World Patient Safety Day. Organised by the World Health Organisation, the day is used to advocate for...
EFA Patients highlights from 2020 online ERS Congress
Although this year it was particularly difficult to choose among the variety and intense 4 full days programme at the 2020 European Respiratory Society...
EFA Food DETECTives Project
In Europe, 17 million people live with food allergies, and the safest option available today remains avoiding the food they are allergic to. Yet this requires...
First CURE project findings published!
The CURE project is now in its third year of research, entering a period of evidence production. On August 4th, the first publication steaming from the...
ImmUniverse: Improving diagnostic and therapeutic options for atopic eczema patients
Through ImmUniverse, EFA is involved in research aiming at improving diagnostic and therapeutic options for patients living with immune-mediated inflammatory...